Original language | English (US) |
---|---|
Pages (from-to) | 31-33 |
Number of pages | 3 |
Journal | The Lancet Neurology |
Volume | 19 |
Issue number | 1 |
DOIs | |
State | Published - Jan 2020 |
ASJC Scopus subject areas
- Clinical Neurology
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: The Lancet Neurology, Vol. 19, No. 1, 01.2020, p. 31-33.
Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - Neuromyelitis optica in patients with increased interferon alpha concentrations
AU - Scottish NMOSD study group
AU - Williams, Jac
AU - McGlasson, Sarah
AU - Irani, Sarosh
AU - Duffy, Darragh
AU - Crow, Yanick
AU - Hunt, David
AU - Katy, Murray
AU - Robert, Wilson
AU - Andrew P, Jackson
AU - Alexa, Jury
AU - Mathieu, Rodero
AU - Vincent, Bondet
AU - Anu, Jacob
AU - Shahd, Hamid
AU - Nuno, Cordeiro
AU - Ondrej, Dolezal
AU - Patrick, Statham
AU - Stewart, Wiseman
AU - Joanna, Wardlaw
AU - Christina, Hertel
AU - Adrian, Hayday
N1 - Funding Information: DH is supported by the Wellcome Trust (215621/Z/19/Z) and the Medical Research Foundation. YC is supported by an European Research Council advanced grant (786142-E-T1IFNs). YC and DH are supported by Connect Immune research (Multiple Sclerosis Society, Juvenile Diabetes Research Foundation, Versus Arthritis). AJ is supported by the UK Medical Research Council. SRI is supported by the Wellcome Trust (104079/Z/14/Z), the British Medical Association's Vera Down (2013) and Margaret Temple (2017) grants, and Epilepsy Research UK (P1201). The research was funded by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre. The views expressed are those of the authors and not necessarily those of the UK National Health Service (NHS), the NIHR, or the UK Department of Health. We thank the Uppsala Monitoring Centre (Uppsala, Sweden) and the UK Medicines and Healthcare products Regulatory Agency for providing spontaneous reporting data. We thank our patients for willingness and consent to report these cases. Patients 1, 3, and 4 were enrolled in clinical studies approved by: Leeds (East) Research Ethics Committee (10/H1307/132; patient 3) and South-East Scotland Research Ethics Committee 01 (14/SS/0003; patients 1 and 4). The Scottish Neuromyelitis Optica Spectrum Disorder Clinic is part of the NHS NMO UK specialised service.
PY - 2020/1
Y1 - 2020/1
UR - http://www.scopus.com/inward/record.url?scp=85076246216&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85076246216&partnerID=8YFLogxK
U2 - 10.1016/S1474-4422(19)30445-4
DO - 10.1016/S1474-4422(19)30445-4
M3 - Letter
C2 - 31839246
AN - SCOPUS:85076246216
SN - 1474-4422
VL - 19
SP - 31
EP - 33
JO - The Lancet Neurology
JF - The Lancet Neurology
IS - 1
ER -